HYDRA BIOSCIENCES
Hydra Biosciences is a biopharmaceutical company based in Cambridge, Massachusetts, develops novel drugs to treat pain, inflammation, cardiovascular and other diseases using its expertise in novel ion channels. Hydra's proprietary high throughput screening platforms enable the company to identify and develop drug candidates that address significant unmet medical needs. Hydra's ion channel drug discovery program is currently focused on channels implicated in pain, inflammation, and cardiovascula... r disease. Hydra's intellectual property portfolio, significant ion channel expertise, and flexible screening systems set it apart from other biopharmaceutical companies. Unlike classical sodium, calcium, or potassium voltage-gated channels Hydra's novel ion channels provide the potential to develop selective and safer ion channel drugs. Hydra has raised significant financing from blue-chip investors since its inception. This prominent group of investors includes Abingworth Ventures, Advanced Technology Ventures, Polaris Ventures, Lilly Bio Ventures, New Enterprise Associates, BioVentures Investors, Biogen Idec, Boston Medical Investors, and MedImmune Ventures.
HYDRA BIOSCIENCES
Social Links:
Industry:
Biotechnology Life Science Medical
Founded:
2001-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.hydrabiosciences.com
Total Employee:
11+
Status:
Active
Contact:
617-494-5230
Email Addresses:
[email protected]
Total Funding:
94.88 M USD
Technology used in webpage:
SPF Apache Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Microsoft Microsoft Azure Network Solutions DNS Confluence Networks Microsoft Azure US North Region
Similar Organizations
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
Current Advisors List
Current Employees Featured
Founder
Investors List
Advanced Technology Ventures
Advanced Technology Ventures investment in Series D - Hydra Biosciences
Biogen Idec
Biogen Idec investment in Series D - Hydra Biosciences
Polaris Partners
Polaris Partners investment in Series D - Hydra Biosciences
Abingworth
Abingworth investment in Series D - Hydra Biosciences
MedImmune Ventures
MedImmune Ventures investment in Series D - Hydra Biosciences
Bioventures Investors
Bioventures Investors investment in Series D - Hydra Biosciences
Lilly Ventures
Lilly Ventures investment in Series D - Hydra Biosciences
Lilly Ventures
Lilly Ventures investment in Series C - Hydra Biosciences
Advanced Technology Ventures
Advanced Technology Ventures investment in Series C - Hydra Biosciences
Polaris Partners
Polaris Partners investment in Series C - Hydra Biosciences
Official Site Inspections
http://www.hydrabiosciences.com
- Host name: 208.91.197.27
- IP address: 208.91.197.27
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago